4 years’ jail for ex-independent director convicted of cheating after failing to declare S$1.5m fee
DeeperDive is a beta AI feature. Refer to full articles for the facts.
THE former lead independent director of a listed healthcare firm was sentenced to four years’ jail on Wednesday (May 17) for failing to declare that he would receive a S$1.5 million fee over the firm’s acquisition of several companies in 2015.
Christopher Chong Meng Tak, 64, who resigned from the Singapore O&G (SOG) board in 2017, had instead taken steps to conceal his interest in the acquisition from parties including the board and the seller of the acquired companies.
As a result, SOG, a women’s and children’s healthcare group, was induced into proceeding with the acquisition at a price of S$26.5 million, with its board unanimously approving the deal at a meeting on Nov 4, 2015.
In February, Chong was convicted of two counts of cheating after a trial.
Before handing down the sentence on Wednesday, District Judge Carol Ling said that the case involved a large sum of money and Chong’s offences involved some degree of planning and premeditation.
She added: “(He) was in a position of trust but he abused it.”
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
In their submissions, the prosecutors had earlier said: “Had the directors of SOG known of the accused’s undisclosed interest, they would not have proceeded with the acquisition… without further conditions or questions.
“The accused then obtained a fee of S$1.5 million by billing the seller using Paromay, a company he owned and controlled.”
Some time between 2013 and 2015, Chong received a recommendation that SOG consider including on its platform Dr Joyce Lim Teng Ee, the founder and director of several companies, such as JL Laser & Surgery Centre.
In early July 2015, she was introduced to him to explore the acquisition of her businesses and medical practices by SOG.
The SOG board of directors held a meeting on Nov 4, 2015, and the acquisition was approved.
On Feb 18, 2016, Chong issued an invoice under Paromay that bore his wife’s signature, addressed to Dr Lim, for the sum of S$1.5 million as payment for items such as “introduction fee” and “consultancy services”.
Dr Lim later made out a cheque for S$1.5 million, which Chong deposited into Paromay’s bank account with Bank Julius Baer (BJB) on March 18, 2016.
Deputy Public Prosecutors David Koh and Daniel Ling had stated in court documents: “It is undisputed that the accused was in a conflict of interest. He was going to receive a fee of S$1.5 million from Dr Lim at the time of the acquisition. The accused would only receive this fee if the acquisition went through.”
The DPPs added that during the trial, all of the prosecution’s witnesses testified that they were unaware of Chong’s interest in the acquisition.
According to court documents, when Chong realised that this payment might be discovered, he instructed his secretary to “never mention Paromay to anyone at SOG ever”.
The DPPs had said: “When the accused needed to encash the cheque of S$1.5 million into Paromay’s account at BJB and was queried about the source of funds, he lied about the source of funds.
They added that Chong deceived BJB into thinking that “the S$1.5 million was (a) ‘shadow equity’ in the business and medical practices of Dr Lim, thereby concealing that this was a fee that he had obtained by way of a concealed conflict of interest”.
Chong, who was offered bail of S$150,000, intends to appeal against his conviction and sentence. THE STRAITS TIMES
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
StarHub hands Ensign InfoSecurity control back to Temasek in S$115 million deal, books S$200 million gain
Singaporeans can now buy record amount of yen per Singdollar
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Keppel DC Reit posts 13.2% higher Q1 DPU of S$0.02833 on strong portfolio performance